Sluch Ilya M, Siatkowski Rhea L, Shah Vinay A
Dean McGee Eye Institute, Oklahoma City, OK.
Cornea. 2016 Aug;35(8):1136-7. doi: 10.1097/ICO.0000000000000879.
To report a case of Mycobacterium chelonae scleral abscess after an intravitreal injection of ranibizumab.
A 54-year-old female received an intravitreal ranibizumab injection for diabetic macular edema. Two weeks postinjection, a scleral abscess developed at the injection site. The patient was treated with incision and drainage of the abscess, subconjunctival injection of amikacin, topical clarithromycin and amikacin, and oral clarithromycin.
After 4 weeks of treatment, the inflammation and infection resolved, and the patient returned to best-corrected preinjection visual acuity.
Injection-site scleral abscesses are very rare and serious complications of intravitreal injections. Once the abscess is drained, it is possible to identify the organism and treat the infection with appropriate combination antibiotic therapy.
报告1例玻璃体内注射雷珠单抗后发生龟分枝杆菌巩膜脓肿的病例。
一名54岁女性因糖尿病性黄斑水肿接受玻璃体内雷珠单抗注射。注射后两周,注射部位出现巩膜脓肿。患者接受了脓肿切开引流、结膜下注射阿米卡星、局部应用克拉霉素和阿米卡星以及口服克拉霉素治疗。
经过4周治疗,炎症和感染消退,患者恢复到注射前最佳矫正视力。
注射部位巩膜脓肿是玻璃体内注射非常罕见且严重的并发症。一旦脓肿引流,就有可能鉴定出病原体并用适当的联合抗生素疗法治疗感染。